We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.21B
AUM Growth
-$47M
Cap. Flow
-$196M
Cap. Flow %
-4.66%
Top 10 Hldgs %
39.32%
Holding
820
New
134
Increased
52
Reduced
63
Closed
277

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$258M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$198M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$128M
4
SEDG icon
SolarEdge
SEDG
+$63M
5
TECK icon
Teck Resources
TECK
+$57.2M

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$131M
2
CRWD icon
CrowdStrike
CRWD
+$91.1M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$88.1M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$64.4M
5
UNM icon
Unum
UNM
+$64.3M

Sector Composition

Rank Sector Weight
1 Financials 18.69%
2 Technology 11.06%
3 Industrials 6.15%
4 Consumer Discretionary 5.6%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JUN.WS
401
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$40.9K ﹤0.01%
250,000
– –
CPAAW
402
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$37.3K ﹤0.01%
250,000
– –
ICNC.WS
403
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
$33.6K ﹤0.01%
250,000
– –
JCICW
404
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$31.5K ﹤0.01%
150,000
– –
MVLAW
405
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$31K ﹤0.01%
200,000
– –
APGB.WS
406
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$28K ﹤0.01%
200,000
– –
ZLSWW
407
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$27K ﹤0.01%
166,666
– –
BTWNW
408
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$26.8K ﹤0.01%
233,333
– –
PNTM.WS
409
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$26.7K ﹤0.01%
333,333
– –
NPABW
410
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$26.7K ﹤0.01%
266,667
– –
ALTIW
411
DELISTED
AlTi Global Inc Warrant
ALTIW
$25.6K ﹤0.01%
50,000
– –
ZTAQW
412
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$25.3K ﹤0.01%
133,333
– –
AFTR.WS
413
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$25K ﹤0.01%
333,333
– –
PEARW
414
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$24.8K ﹤0.01%
166,666
– –
LOCL.WS
415
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$24.7K ﹤0.01%
150,000
– –
VLD.WS
416
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$20.5K ﹤0.01%
100,000
– –
GGAAW
417
DELISTED
Genesis Growth Tech Acquisition Corp. Warrant
GGAAW
$20.3K ﹤0.01%
75,000
– –
SKGRW
418
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$20K ﹤0.01%
200,000
– –
GFGDR
419
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
$20K ﹤0.01%
500,000
– –
CTAQW
420
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$20K ﹤0.01%
333,333
– –
CVIIW
421
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$19.8K ﹤0.01%
400,000
– –
SCRMW
422
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$19.6K ﹤0.01%
83,333
– –
RBOT.WS
423
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$18.8K ﹤0.01%
125,000
– –
PIIIW icon
424
P3 Health Partners Inc Warrant
PIIIW
$179K
$18.7K ﹤0.01%
133,333
– –
THCHW
425
DELISTED
TH International Limited Warrant
THCHW
$18K ﹤0.01%
150,000
– –
15 16
17
18 19

Similar funds

SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return

Moore Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Moore Capital Management held 820 positions worth $4.21B, down 1.1% from $4.26B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Moore Capital Management withdrew a net $196M in Q4 2022, closing 277 positions and reducing 63 holdings. Its most notable exit was CrowdStrike, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $264M.

  • Moore Capital Management's largest Q4 2022 buy was State Street SPDR S&P Biotech ETF: 3,182,662 shares worth $264M.
  • Moore Capital Management added most to SolarEdge in Q4 2022, an estimated $63M increase.
  • Moore Capital Management's biggest Q4 2022 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $131M.
  • Moore Capital Management fully exited CrowdStrike in Q4 2022, selling an estimated $91.1M.
  • Moore Capital Management's ten largest holdings make up 39% of its $4.21B portfolio in Q4 2022.
  • Moore Capital Management opened 134 new positions and closed 277 in Q4 2022.
  • Moore Capital Management's portfolio value fell 1.1% quarter-over-quarter to $4.21B.

Based on Moore Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.